Fennec Pharmaceuticals (FENC) Cash from Operations Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -304.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -304.48% |
| Sep 30, 2025 | 167.68% |
| Jun 30, 2025 | 56.05% |
| Mar 31, 2025 | -111.06% |
| Dec 31, 2024 | 69.67% |
| Sep 30, 2024 | 20.07% |
| Jun 30, 2024 | -112.54% |
| Mar 31, 2024 | 800.14% |
| Dec 31, 2023 | 28.55% |
| Sep 30, 2023 | 44.91% |
| Jun 30, 2023 | -16.40% |
| Mar 31, 2023 | -95.27% |
| Dec 31, 2022 | -109.61% |
| Sep 30, 2022 | -69.37% |
| Jun 30, 2022 | 23.41% |
| Mar 31, 2022 | 20.51% |
| Dec 31, 2021 | 1.19% |
| Sep 30, 2021 | 45.68% |
| Jun 30, 2021 | -42.04% |
| Mar 31, 2021 | 4.16% |
| Dec 31, 2020 | -106.54% |
| Sep 30, 2020 | -143.67% |
| Jun 30, 2020 | -13.06% |
| Mar 31, 2020 | -51.23% |
| Dec 31, 2019 | 45.73% |
| Sep 30, 2019 | -39.77% |
| Jun 30, 2019 | -75.54% |
| Mar 31, 2019 | -43.54% |
| Dec 31, 2018 | -121.97% |
| Sep 30, 2018 | -66.91% |
| Jun 30, 2018 | -128.20% |
| Mar 31, 2018 | -155.85% |
| Dec 31, 2017 | -116.04% |
| Sep 30, 2017 | -76.10% |
| Jun 30, 2017 | -46.38% |
| Mar 31, 2017 | -35.27% |
| Dec 31, 2016 | -44.10% |
| Sep 30, 2016 | -6.88% |
| Jun 30, 2016 | 8.02% |
| Mar 31, 2016 | -19.38% |
| Dec 31, 2015 | 9.40% |
| Sep 30, 2015 | -14.90% |
| Jun 30, 2015 | -24.63% |
| Mar 31, 2015 | -10.58% |
| Dec 31, 2014 | -5.17% |
| Sep 30, 2014 | 5.54% |
| Jun 30, 2014 | 53.88% |
| Mar 31, 2014 | 7.13% |
| Dec 31, 2013 | 20.11% |
| Sep 30, 2013 | 35.40% |
| Jun 30, 2013 | 21.54% |
| Mar 31, 2013 | 29.58% |
| Dec 31, 2012 | 27.38% |
| Sep 30, 2012 | -14.15% |
| Jun 30, 2012 | -163.94% |
| Mar 31, 2012 | 44.85% |
| Dec 31, 2011 | -17.10% |
| Sep 30, 2011 | -15.64% |
| Jun 30, 2011 | 559.07% |